A Screen for Novel Phosphoinositide 3-kinase Effector Proteins

被引:20
作者
Dixon, Miles J. [1 ]
Gray, Alexander [1 ]
Boisvert, Francois-Michel [2 ]
Agacan, Mark [4 ]
Morrice, Nicholas A. [3 ]
Gourlay, Robert [3 ]
Leslie, Nicholas R. [1 ]
Downes, C. Peter [1 ]
Batty, Ian H. [1 ]
机构
[1] Univ Dundee, Div Mol Physiol, Dundee DD1 5EH, Scotland
[2] Univ Dundee, Div Gene Regulat & Express, Dundee DD1 5EH, Scotland
[3] Univ Dundee, MRC Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland
[4] Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee DD1 5EH, Scotland
基金
英国惠康基金; 英国生物技术与生命科学研究理事会; 英国医学研究理事会;
关键词
PLECKSTRIN-HOMOLOGY-DOMAIN; PHOSPHATIDYLINOSITOL 3,4-BISPHOSPHATE; QUANTITATIVE PROTEOMICS; IN-VIVO; PHOSPHATASE SHIP2; BINDING DOMAINS; PH DOMAIN; MEMBRANE; IDENTIFICATION; CELLS;
D O I
10.1074/mcp.M110.003178
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Class I phosphoinositide 3-kinases exert important cellular effects through their two primary lipid products, phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P-2). As few molecular targets for PtdIns(3,4)P-2 have yet been identified, a screen for PI 3-kinase-responsive proteins that is selective for these is described. This features a tertiary approach incorporating a unique, primary recruitment of target proteins in intact cells to membranes selectively enriched in PtdIns(3,4)P-2. A secondary purification of these proteins, optimized using tandem pleckstrin homology domain containing protein-1 (TAPP-1), an established PtdIns(3,4)P-2 selective ligand, yields a fraction enriched in proteins of potentially similar lipid binding character that are identified by liquid chromatography-tandem MS. Thirdly, this approach is coupled to stable isotope labeling with amino acids in cell culture using differential isotope labeling of cells stimulated in the absence and presence of the PI 3-kinase inhibitor wortmannin. This provides a ratio-metric readout that distinguishes authentically responsive components from copurifying background proteins. Enriched fractions thus obtained from astrocytoma cells revealed a subset of proteins that exhibited ratios indicative of their initial, cellular responsiveness to PI 3-kinase activation. The inclusion among these of tandem pleckstrin homology domain containing protein-1, three isoforms of Akt, switch associated protein-70, early endosome antigen-1 and of additional proteins expressing recognized lipid binding domains demonstrates the utility of this strategy and lends credibility to the novel candidate proteins identified. The latter encompass a broad set of proteins that include the gene product of TBC1D2A, a putative Rab guanine nucleotide triphosphatase activating protein (GAP) and IQ motif containing GAP1, a potential tumor promoter. A sequence comparison of the former protein indicates the presence of a pleckstrin homology domain whose lipid binding character remains to be established. IQ motif containing GAP1 lacks known lipid interacting components and a preliminary analysis here indicates that this may exemplify a novel class of atypical phosphoinositide (aPI) binding domain. Molecular & Cellular Proteomics 10: 10.1074/mcp.M110.003178, 1-13, 2011.
引用
收藏
页数:13
相关论文
共 50 条
[41]   Pityriasis rubra pilaris-like erythroderma secondary to phosphoinositide 3-kinase inhibition [J].
Dewan, A. K. ;
Sowerby, L. ;
Jadeja, S. ;
Lian, C. ;
Wen, P. ;
Brown, J. R. ;
Fisher, D. C. ;
LeBoeuf, N. R. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2018, 43 (08) :890-894
[42]   Assessing the subcellular distribution of oncogenic phosphoinositide 3-kinase using microinjection into live cells [J].
Layton, Meredith J. ;
Rynkiewicz, Natalie K. ;
Ivetac, Ivan ;
Horan, Kristy A. ;
Mitchell, Christina A. ;
Phillips, Wayne A. .
BIOSCIENCE REPORTS, 2014, 34 :165-180
[43]   Inhibition of the α-Subunit of Phosphoinositide 3-Kinase in Heart Increases Late Sodium Current and Is Arrhythmogenic [J].
Yang, Tao ;
Meoli, David F. ;
Moslehi, Javid ;
Roden, Dan M. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 365 (03) :460-466
[44]   Phosphoinositide 3-Kinase Signaling Can Modulate MHC Class I and II Expression [J].
Chandrasekaran, Sanjay ;
Sasaki, Maiko ;
Scharer, Christopher D. ;
Kissick, Haydn T. ;
Patterson, Dillon G. ;
Magliocca, Kelly R. ;
Seykora, John T. ;
Sapkota, Bishu ;
Gutman, David A. ;
Cooper, Lee A. ;
Lesinski, Gregory B. ;
Waller, Edmund K. ;
Thomas, Susan N. ;
Kotenko, Sergei V. ;
Boss, Jeremy M. ;
Moreno, Carlos S. ;
Swerlick, Robert A. ;
Pollack, Brian P. .
MOLECULAR CANCER RESEARCH, 2019, 17 (12) :2395-2409
[45]   Phosphatidylinositol 3-Kinase: The Oncoprotein [J].
Vogt, Peter K. ;
Hart, Jonathan R. ;
Gymnopoulos, Marco ;
Jiang, Hao ;
Kang, Sohye ;
Bader, Andreas G. ;
Zhao, Li ;
Denley, Adam .
PHOSPHOINOSITIDE 3-KINASE IN HEALTH AND DISEASE, VOL 2, 2011, 347 :79-104
[46]   Phosphoinositide 3-Kinase γ Regulates Airway Smooth Muscle Contraction by Modulating Calcium Oscillations [J].
Jiang, Haihong ;
Abel, Peter W. ;
Toews, Myron L. ;
Deng, Caishu ;
Casale, Thomas B. ;
Xie, Yan ;
Tu, Yaping .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (03) :703-709
[47]   Prevention of the wortmannin-induced inhibition of phosphoinositide 3-kinase by sulfhydryl reducing agents [J].
Isosaki, Minoru ;
Nakayama, Hitoshi ;
Kyotani, Yoji ;
Zhao, Jing ;
Tomita, Sayuko ;
Satoh, Hiroyasu ;
Yoshizumi, Masanori .
PHARMACOLOGICAL REPORTS, 2011, 63 (03) :733-739
[48]   Discovery of Novel Dual Poly(ADP-ribose)polymerase and Phosphoinositide 3-Kinase Inhibitors as a Promising Strategy for Cancer Therapy [J].
Wang, Junwei ;
Li, Hui ;
He, Guangchao ;
Chu, Zhaoxing ;
Peng, Kewen ;
Ge, Yiran ;
Zhu, Qihua ;
Xu, Yungen .
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (01) :122-139
[49]   A Novel Oncolytic Herpes Simplex Virus that Synergizes with Phosphoinositide 3-kinase/Akt Pathway Inhibitors to Target Glioblastoma Stem Cells [J].
Kanai, Ryuichi ;
Wakimoto, Hiroaki ;
Martuza, Robert L. ;
Rabkin, Samuel D. .
CLINICAL CANCER RESEARCH, 2011, 17 (11) :3686-3696
[50]   Characterization of IIPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class Ill phosphoinositide 3-kinase [J].
Bago, Ruzica ;
Malik, Nazma ;
Munson, Michael J. ;
Prescott, Alan R. ;
Davies, Paul ;
Sommer, Eeva ;
Shpiro, Natalia ;
Ward, Richard ;
Cross, Darren ;
Ganley, Ian G. ;
Alessi, Dario R. .
BIOCHEMICAL JOURNAL, 2014, 463 :413-427